SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-002611
Filing Date
2018-02-26
Accepted
2018-02-26 17:02:16
Documents
113
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2572801
2 ex10-56.htm EX-10.56 100798
3 ex10-57.htm EX-10.57 22987
4 ex10-58.htm EX-10.58 26608
5 ex10-59.htm EX-10.59 51914
6 ex21-1.htm EX-21.1 4317
7 ex23-1.htm EX-23.1 4270
8 ex23-2.htm EX-23.2 4209
9 ex31-1.htm EX-31.1 18845
10 ex31-2.htm EX-31.2 17641
11 ex32-1.htm EX-32.1 5981
12 ex32-2.htm EX-32.2 6212
13 image_001.jpg GRAPHIC 35576
14 maindoc_2.jpg GRAPHIC 40721
  Complete submission text file 0001493152-18-002611.txt   8535581

Data Files

Seq Description Document Type Size
15 XBRL INSTANCE FILE vbiv-20171231.xml EX-101.INS 1258098
16 XBRL SCHEMA FILE vbiv-20171231.xsd EX-101.SCH 76722
17 XBRL CALCULATION FILE vbiv-20171231_cal.xml EX-101.CAL 87979
18 XBRL DEFINITION FILE vbiv-20171231_def.xml EX-101.DEF 331486
19 XBRL LABEL FILE vbiv-20171231_lab.xml EX-101.LAB 525458
20 XBRL PRESENTATION FILE vbiv-20171231_pre.xml EX-101.PRE 453330
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37769 | Film No.: 18641439
SIC: 2834 Pharmaceutical Preparations